<p>(<b>A</b>) K562 cells were cultured with various concentrations of BIX01294 and imatinib as indicated. After four days, cell proliferation was measured with a MTT assay. Results represent the mean ± SD in quadruplicate experiments. (<b>B</b>) K562 cells were treated with or without IFNα2a (15 k IU/ml), or imatinib (150 nM) in the presence or absence of BIX01294 (2 µM) for 2 days. Cells were washed with PBS and fixed with 70% ethanol. Fixed cells were then stained with PI and analyzed with FACS. (<b>C</b>) K562 cells were stimulated with or without IFNα2a (10 k IU/ml), or imatinib (75 nM) in the presence or absence of BIX01294 (2 µM) for 2 days. Whole cell extracts were prepared and subjected to immunoblotting using the indicated antibodi...
Apoptosis (programmed cell death) was first described 40 years ago, and has been the subject of acti...
<p>(A) Soft agar colony formation assay was performed in K562 cells after treatment with NC (4 μM), ...
<p>(<b>A</b>) Nuclear lysates from doxorubin (0.5 µM-top; 1 µM-bottom)/imatinib (10 µM)-treated 435s...
<p>Jurkat (<b>A</b>), HeLa (<b>B</b>) and HaCat (<b>C</b>) cells were cultured with various concentr...
<p>K562 (<b>A</b>), KCL22 (<b>B</b>), BV173 (<b>C</b>) and KT1 (<b>D</b>) cells were cultured with v...
<p>(<b>A</b>) K562 cells were incubated with 2.5 µM BIX01294 for 24 hours. The cells were then treat...
<p>(A) Calu-6 and H3122 cells were transfected with Bim-specific or control siRNA and then treated w...
<p><b>A</b>) NOXA expression is decreased in C42Luc cells treated with the combination of ZSTK474 an...
<p>(A) A549 and H157 were treated with AZD6244, MK2206, or a combination of these two compounds at t...
<p>(A) HCT-116 wt and HCT-116 p53 -/- cells were transfected with BIK siRNA or scrambled siRNA for 2...
<p><b>A.</b> The cells were treated with 50 U/ml, 100 U/ml, or 150 U/ml IFN-γ for 24 hrs. MTT assay ...
<p>(A) Cells were treated with MX (0.6 µM), DXR (0.8 µM), imatinib (5 µM) or their combinations for ...
Background: H3K9 methylation is one of the essential histone post-translational modifications for he...
<p>A, knockdown of Bim attenuated the apoptosis in EOL-1 cells. EOL-1 cells were transfected with hu...
<p>(<b>A, B</b>) 435s/M14 cells were treated with imatinib (10 µM) (<b>A</b>) or transfected with ST...
Apoptosis (programmed cell death) was first described 40 years ago, and has been the subject of acti...
<p>(A) Soft agar colony formation assay was performed in K562 cells after treatment with NC (4 μM), ...
<p>(<b>A</b>) Nuclear lysates from doxorubin (0.5 µM-top; 1 µM-bottom)/imatinib (10 µM)-treated 435s...
<p>Jurkat (<b>A</b>), HeLa (<b>B</b>) and HaCat (<b>C</b>) cells were cultured with various concentr...
<p>K562 (<b>A</b>), KCL22 (<b>B</b>), BV173 (<b>C</b>) and KT1 (<b>D</b>) cells were cultured with v...
<p>(<b>A</b>) K562 cells were incubated with 2.5 µM BIX01294 for 24 hours. The cells were then treat...
<p>(A) Calu-6 and H3122 cells were transfected with Bim-specific or control siRNA and then treated w...
<p><b>A</b>) NOXA expression is decreased in C42Luc cells treated with the combination of ZSTK474 an...
<p>(A) A549 and H157 were treated with AZD6244, MK2206, or a combination of these two compounds at t...
<p>(A) HCT-116 wt and HCT-116 p53 -/- cells were transfected with BIK siRNA or scrambled siRNA for 2...
<p><b>A.</b> The cells were treated with 50 U/ml, 100 U/ml, or 150 U/ml IFN-γ for 24 hrs. MTT assay ...
<p>(A) Cells were treated with MX (0.6 µM), DXR (0.8 µM), imatinib (5 µM) or their combinations for ...
Background: H3K9 methylation is one of the essential histone post-translational modifications for he...
<p>A, knockdown of Bim attenuated the apoptosis in EOL-1 cells. EOL-1 cells were transfected with hu...
<p>(<b>A, B</b>) 435s/M14 cells were treated with imatinib (10 µM) (<b>A</b>) or transfected with ST...
Apoptosis (programmed cell death) was first described 40 years ago, and has been the subject of acti...
<p>(A) Soft agar colony formation assay was performed in K562 cells after treatment with NC (4 μM), ...
<p>(<b>A</b>) Nuclear lysates from doxorubin (0.5 µM-top; 1 µM-bottom)/imatinib (10 µM)-treated 435s...